Tag Archives: Patent Law

NOVARTIS A.G. v. UOI – What is Novelty in Indian Courts?

Posted on April 8, 2013 by Warren Woessner

Can everything old be made new again? Lots has been written about the Indian Supreme Court rejecting a patent application claiming a crystal modification of imatinib mesylate (Gleevec), which is used to treat CML. Novartis’ attempt to “evergreen” Gleevec with … Continue reading →

Posted in Int'l Practice and Policy, Obviousness | Tagged Indian Supreme Court, Lakshmikumaran & Sridharan, Novartis, Patent Law, Warren Woessner | Leave a comment

Federal Court Affirms BPAI in Dawson v. Dawson and Bowman

Posted on March 27, 2013 by Warren Woessner

This is a guest post from Theresa Stadheim of Schwegman Lundberg & Woessner In Chandler Dawson v. Chandler Dawson and Lyle Bowman, Appeal Nos. 2012-1214,-1215,-1216, -1217 (Fed. Cir. March 25, 2013) (a copy can be found at the end of … Continue reading →

Posted in Inventorship | Tagged biotechnology, biotechnology law, biotechnology news, BPAI, Dawson v Dawson, Federal Circuit, intellectual property, ip, Patent Law, patents, theresa Stadheim, Warren Woessner | Leave a comment

Patents4Life is Four Years Old

Posted on March 26, 2013 by Warren Woessner

On March 24th, Patents4Life forgot to celebrate its 4th anniversary. On March 24, 2009, I started the blog (or is it “blawg”) by posting three articles on fairly recent Fed. Cir. decisions. One of the articles discussed the application of … Continue reading →

Posted in Miscellaneous | Tagged Bilski, Classen, Federal Circuit, Patent Law, Supreme Court, Warren Woessner | 1 Comment

In Re Hubbell

Posted on March 20, 2013 by Warren Woessner

Guest post by Theresa Stadheim of Schwegman Lundberg & Woessner) In In Re Jeffrey Hubbell, Jason Schense, Andreas Zisch, and Heike Hall, Appeal No. 2011-1547 (Fed. Cir. March 7, 2013) (a copy can be found at the end of this post), … Continue reading →